A comprehensive study by The GRADE Study Research Group has provided valuable insights into the effectiveness of four widely used diabetes medications when combined with metformin, a primary treatment for type 2 diabetes.
The study aimed to determine which drug best maintains blood glucose levels within the recommended range.
Study Overview and Results
The study involved 5,047 individuals with type 2 diabetes from various backgrounds. All participants were initially taking metformin and were randomly assigned to one of four groups, each receiving an additional diabetes medication: sitagliptin, liraglutide, glimepiride, or insulin glargine U-100.
Over an average follow-up period of four years, the researchers discovered that liraglutide and insulin glargine, when combined with metformin, were more effective in achieving and maintaining target blood glucose levels compared to sitagliptin and glimepiride.
The effectiveness of these treatments appeared consistent across different age groups, genders, races, and ethnicities.
Despite these findings, maintaining target blood glucose levels over the long term proved challenging, with about three-quarters of the participants unable to sustain the desired levels for four years. This highlights the complexity of long-term diabetes management.
Implications for Type 2 Diabetes Treatment
The study underscores the relative effectiveness of liraglutide and insulin glargine, alongside metformin, in controlling blood sugar levels in type 2 diabetes patients.
The difficulty in maintaining target glucose levels over extended periods emphasizes the need for ongoing research and development of more effective diabetes management strategies.
An interesting side finding revealed that participants taking liraglutide experienced fewer instances of diabetes-related cardiovascular diseases compared to other groups, indicating potential additional benefits of this medication.
Conclusion
This study provides valuable insights into the comparative effectiveness of different diabetes medications when used in conjunction with metformin.
While liraglutide and insulin glargine showed better performance in maintaining blood glucose levels, the challenge of long-term management remains.
These findings can guide healthcare professionals in making more informed decisions about diabetes treatment plans, considering individual patient needs and health profiles.
Further research is essential to explore more effective long-term solutions for managing type 2 diabetes. The study, led by Dr. Henry Burch, was published in The New England Journal of Medicine.
If you care about diabetes, please read studies about How to choosing the right fruits for type 2 diabetes and findings of New higher dose diabetes drug promises better blood sugar control and weight loss.
For more information about diabetes, please see recent studies about bone drug that could lower risk of type 2 diabetes, and results showing eating more eggs linked to higher risk of type 2 diabetes.
Copyright © 2023 Knowridge Science Report. All rights reserved.
